Central Venous Catheter–associatedNocardiaBacteremia in Cancer Patients
Open Access
- 1 September 2011
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 17 (9), 1651-1658
- https://doi.org/10.3201/eid1709.101810
Abstract
TOC Summary: Heavy biofilm growth can be reduced through use of antimicrobial lock solutions.Keywords
This publication has 27 references indexed in Scilit:
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratoriesClinical Microbiology & Infection, 2008
- Comparative In Vitro Efficacies and Antimicrobial Durabilities of Novel Antimicrobial Central Venous CathetersAntimicrobial Agents and Chemotherapy, 2006
- Nocardiosis in Cancer PatientsMedicine, 2002
- Central Venous Catheter–AssociatedNocardiaBacteremiaClinical Infectious Diseases, 2001
- Central Venous Catheter-Associated Nocardia Bacteremia: An Unusual Manifestation of NocardiosisClinical Infectious Diseases, 2000
- Nocardia Bacteremia: Report of 4 Cases and Review of the LiteratureMedicine, 1998
- NocardiosisClinical Infectious Diseases, 1996
- The medically important aerobic actinomycetes: epidemiology and microbiologyClinical Microbiology Reviews, 1994
- Nocardia species: host-parasite relationshipsClinical Microbiology Reviews, 1994